AMYRIS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.002 USD | 0.00% |
|
-60.00% | -20.00% |
| 05-07 | Han Kieftenbeld to leave as Chief Financial Officer of Amyris, Inc | CI |
| 05-07 | Kathy L. Fortmann to Join Amyris, Inc. as Member of the Board of Directors | CI |
Presentation Operator MessageOperator (Operator)Welcome to the Amyris First Quarter 2017 Confe...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Companyâs sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The Company leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.
Sector
Specialty Chemicals
| 1st Jan change | Capi. | |
|---|---|---|
| -20.00% | 745K | |
| +17.69% | 66.69B | |
| +1.79% | 49.2B | |
| +17.80% | 41.24B | |
| +20.17% | 25.89B | |
| +12.56% | 19.81B | |
| +2.67% | 17.11B | |
| -23.12% | 15.86B | |
| +2.62% | 15.35B | |
| -8.19% | 15.23B |
- Stock Market
- Equities
- AMRS Stock
- News Amyris, Inc.
- Transcript : Amyris, Inc., Q1 2017 Earnings Call, May 15, 2017
